Kyntra Bio, Inc. (KYNB) stock
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−1.16 (-36.25%)
Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –
Kyntra Bio pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Kyntra Bio's pe ratio was 0.1× on Nov 11, 2026, against 0.2× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −0.1 |
| 2025 | Dec 31, 2025 | 0.2× | −102.9 |
| 2020 | Jan 31, 2020 | 103.1× | −2.6 |
| 2019 | Dec 31, 2019 | 105.6× | – |
See a number that looks wrong?